LSIPR 50 2017: Michael Salzmann

10-11-2017

Michael Salzmann was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.

michael-salzmann.jpg

Name: Michael Salzmann

Organisation: Neurimmune


LSIPR 50 2017, Michael Salzmann, Neurimmune, human monoclonal antibody, biopharma, therapeutics, Alzheimer's, Parkinson's

LSIPR